The Egyptian pharma market grew at a compound annual growth rate (CAGR) of 17 percent between 2011 and 2017 to reach a total market valuation of EGP 50 billion in 2017. Low levels of healthcare insurance penetration mean that pharma sales are predominantly driven by out-of-pocket expenditure.
  The top 10 generics companies in the Egyptian market for 2017 by market share. Local champion Pharco leads the way with a seven percent market share, followed by Amoun (APC) and EIPICO, both with five percent market shares.
  Egypt has by far and away the largest number of pharmacists per capita in its region, boasting 212 per 1,000 of its population.
  Egypt has around 60 pharmacies for every 1,000 of its population.